<unk>  (trade names Azopt, Alcon Laboratories, Befardin, Fardi Medicals, ) is a carbonic anhydrase inhibitor used to lower intraocular pressure in patients with open-angle glaucoma or ocular hypertension.<unk>  was approved as a generic medication in the United States in November 2020.
Brinzolamide
Dorzolamide
Etizolam
Acetazolamide
Avanafil
Bifluranol
Felodipine
Terguride